SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kwality Pharmaceuticals informs about disclosure of related party transactions

29 Nov 2022 Evaluate

In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kwality Pharmaceuticals has informed that it enclosed disclosure of related party transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/ CIR/P/2021/662 dated November 22, 2021, for the half year ended September 30, 2022. The aforesaid details of related party transaction will also be available on the Company's website at www.kwalitypharma.com

The above information is a part of company’s filings submitted to BSE.

Kwality Pharma Share Price

2688.65 17.95 (0.67%)
24-Jul-2026 09:47 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1958.55
Dr. Reddys Labs. 1149.00
Cipla 1427.95
Lupin 2370.00
Zydus Lifesciences 1113.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: